JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $33 from $40 and keeps an Underweight rating on the shares, ...
Some pearl-shaped bubble foods have been with us for a long time — not fads at all. Perhaps the classic is caviar, and fish eggs in general. Different fish eggs have different types of “pop” and ...
Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...
National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...
Real-time stock price for BMO Callable Equity Inc Notes S2641 Link Moderna (JHN14879.CF), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around ...
The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com ...
12d
MarketBeat on MSNModerna: 4 Key Reasons the CEO Just Bought $5M in SharesCompanyOverview|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.
Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine ...
This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...
Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results